The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lyme Disease IgG ELISA Kit Market Research Report 2025
Synopsis
The Lyme Disease IgG ELISA Kit is a diagnostic tool used to detect the presence of IgG antibodies against Borrelia burgdorferi, the bacterium that causes Lyme disease. ELISA stands for Enzyme-Linked Immunosorbent Assay, which is a common laboratory technique used to detect and measure specific substances, such as antibodies or antigens, in a sample.
Global Lyme Disease IgG ELISA Kit market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lyme Disease IgG ELISA Kit market research.
Key manufacturers engaged in the Lyme Disease IgG ELISA Kit industry include Zoetics, LetsgetChecked, Creative Diagnostics, Zeus Scientific, Novatein Bioscience, Serion Diagnostics, Medline, Igenex and GeneProof, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Lyme Disease IgG ELISA Kit were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Lyme Disease IgG ELISA Kit market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Lyme Disease IgG ELISA Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Zoetics
LetsgetChecked
Creative Diagnostics
Zeus Scientific
Novatein Bioscience
Serion Diagnostics
Medline
Igenex
GeneProof
Thermo Fisher Scientific
Everlywell
Cortez Diagnostics
Pyramid
Abcam
Fujirebio
Segment by Type
Lyme Disease IgG ELISA Kit for Diagnostics
Lyme Disease IgG ELISA Kit for Research
Segment by Application
Medical
Scientific Research
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Lyme Disease IgG ELISA Kit report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
The Lyme Disease IgG ELISA Kit is a diagnostic tool used to detect the presence of IgG antibodies against Borrelia burgdorferi, the bacterium that causes Lyme disease. ELISA stands for Enzyme-Linked Immunosorbent Assay, which is a common laboratory technique used to detect and measure specific substances, such as antibodies or antigens, in a sample.
Global Lyme Disease IgG ELISA Kit market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lyme Disease IgG ELISA Kit market research.
Key manufacturers engaged in the Lyme Disease IgG ELISA Kit industry include Zoetics, LetsgetChecked, Creative Diagnostics, Zeus Scientific, Novatein Bioscience, Serion Diagnostics, Medline, Igenex and GeneProof, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Lyme Disease IgG ELISA Kit were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Lyme Disease IgG ELISA Kit market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Lyme Disease IgG ELISA Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Zoetics
LetsgetChecked
Creative Diagnostics
Zeus Scientific
Novatein Bioscience
Serion Diagnostics
Medline
Igenex
GeneProof
Thermo Fisher Scientific
Everlywell
Cortez Diagnostics
Pyramid
Abcam
Fujirebio
Segment by Type
Lyme Disease IgG ELISA Kit for Diagnostics
Lyme Disease IgG ELISA Kit for Research
Segment by Application
Medical
Scientific Research
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Lyme Disease IgG ELISA Kit report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Lyme Disease IgG ELISA Kit Market Overview
1.1 Product Overview and Scope of Lyme Disease IgG ELISA Kit
1.2 Lyme Disease IgG ELISA Kit Segment by Type
1.2.1 Global Lyme Disease IgG ELISA Kit Market Value Comparison by Type (2023-2029)
1.2.2 Lyme Disease IgG ELISA Kit for Diagnostics
1.2.3 Lyme Disease IgG ELISA Kit for Research
1.3 Lyme Disease IgG ELISA Kit Segment by Application
1.3.1 Global Lyme Disease IgG ELISA Kit Market Value by Application: (2023-2029)
1.3.2 Medical
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Lyme Disease IgG ELISA Kit Market Size Estimates and Forecasts
1.4.1 Global Lyme Disease IgG ELISA Kit Revenue 2018-2029
1.4.2 Global Lyme Disease IgG ELISA Kit Sales 2018-2029
1.4.3 Global Lyme Disease IgG ELISA Kit Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Lyme Disease IgG ELISA Kit Market Competition by Manufacturers
2.1 Global Lyme Disease IgG ELISA Kit Sales Market Share by Manufacturers (2018-2023)
2.2 Global Lyme Disease IgG ELISA Kit Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Lyme Disease IgG ELISA Kit Average Price by Manufacturers (2018-2023)
2.4 Global Lyme Disease IgG ELISA Kit Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Lyme Disease IgG ELISA Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lyme Disease IgG ELISA Kit, Product Type & Application
2.7 Lyme Disease IgG ELISA Kit Market Competitive Situation and Trends
2.7.1 Lyme Disease IgG ELISA Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lyme Disease IgG ELISA Kit Players Market Share by Revenue
2.7.3 Global Lyme Disease IgG ELISA Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lyme Disease IgG ELISA Kit Retrospective Market Scenario by Region
3.1 Global Lyme Disease IgG ELISA Kit Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Lyme Disease IgG ELISA Kit Global Lyme Disease IgG ELISA Kit Sales by Region: 2018-2029
3.2.1 Global Lyme Disease IgG ELISA Kit Sales by Region: 2018-2023
3.2.2 Global Lyme Disease IgG ELISA Kit Sales by Region: 2024-2029
3.3 Global Lyme Disease IgG ELISA Kit Global Lyme Disease IgG ELISA Kit Revenue by Region: 2018-2029
3.3.1 Global Lyme Disease IgG ELISA Kit Revenue by Region: 2018-2023
3.3.2 Global Lyme Disease IgG ELISA Kit Revenue by Region: 2024-2029
3.4 North America Lyme Disease IgG ELISA Kit Market Facts & Figures by Country
3.4.1 North America Lyme Disease IgG ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Lyme Disease IgG ELISA Kit Sales by Country (2018-2029)
3.4.3 North America Lyme Disease IgG ELISA Kit Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lyme Disease IgG ELISA Kit Market Facts & Figures by Country
3.5.1 Europe Lyme Disease IgG ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Lyme Disease IgG ELISA Kit Sales by Country (2018-2029)
3.5.3 Europe Lyme Disease IgG ELISA Kit Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lyme Disease IgG ELISA Kit Market Facts & Figures by Country
3.6.1 Asia Pacific Lyme Disease IgG ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Lyme Disease IgG ELISA Kit Sales by Country (2018-2029)
3.6.3 Asia Pacific Lyme Disease IgG ELISA Kit Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lyme Disease IgG ELISA Kit Market Facts & Figures by Country
3.7.1 Latin America Lyme Disease IgG ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Lyme Disease IgG ELISA Kit Sales by Country (2018-2029)
3.7.3 Latin America Lyme Disease IgG ELISA Kit Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lyme Disease IgG ELISA Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Lyme Disease IgG ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Lyme Disease IgG ELISA Kit Sales by Country (2018-2029)
3.8.3 Middle East and Africa Lyme Disease IgG ELISA Kit Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lyme Disease IgG ELISA Kit Sales by Type (2018-2029)
4.1.1 Global Lyme Disease IgG ELISA Kit Sales by Type (2018-2023)
4.1.2 Global Lyme Disease IgG ELISA Kit Sales by Type (2024-2029)
4.1.3 Global Lyme Disease IgG ELISA Kit Sales Market Share by Type (2018-2029)
4.2 Global Lyme Disease IgG ELISA Kit Revenue by Type (2018-2029)
4.2.1 Global Lyme Disease IgG ELISA Kit Revenue by Type (2018-2023)
4.2.2 Global Lyme Disease IgG ELISA Kit Revenue by Type (2024-2029)
4.2.3 Global Lyme Disease IgG ELISA Kit Revenue Market Share by Type (2018-2029)
4.3 Global Lyme Disease IgG ELISA Kit Price by Type (2018-2029)
5 Segment by Application
5.1 Global Lyme Disease IgG ELISA Kit Sales by Application (2018-2029)
5.1.1 Global Lyme Disease IgG ELISA Kit Sales by Application (2018-2023)
5.1.2 Global Lyme Disease IgG ELISA Kit Sales by Application (2024-2029)
5.1.3 Global Lyme Disease IgG ELISA Kit Sales Market Share by Application (2018-2029)
5.2 Global Lyme Disease IgG ELISA Kit Revenue by Application (2018-2029)
5.2.1 Global Lyme Disease IgG ELISA Kit Revenue by Application (2018-2023)
5.2.2 Global Lyme Disease IgG ELISA Kit Revenue by Application (2024-2029)
5.2.3 Global Lyme Disease IgG ELISA Kit Revenue Market Share by Application (2018-2029)
5.3 Global Lyme Disease IgG ELISA Kit Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Zoetics
6.1.1 Zoetics Corporation Information
6.1.2 Zoetics Description and Business Overview
6.1.3 Zoetics Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Zoetics Lyme Disease IgG ELISA Kit Product Portfolio
6.1.5 Zoetics Recent Developments/Updates
6.2 LetsgetChecked
6.2.1 LetsgetChecked Corporation Information
6.2.2 LetsgetChecked Description and Business Overview
6.2.3 LetsgetChecked Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.2.4 LetsgetChecked Lyme Disease IgG ELISA Kit Product Portfolio
6.2.5 LetsgetChecked Recent Developments/Updates
6.3 Creative Diagnostics
6.3.1 Creative Diagnostics Corporation Information
6.3.2 Creative Diagnostics Description and Business Overview
6.3.3 Creative Diagnostics Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Creative Diagnostics Lyme Disease IgG ELISA Kit Product Portfolio
6.3.5 Creative Diagnostics Recent Developments/Updates
6.4 Zeus Scientific
6.4.1 Zeus Scientific Corporation Information
6.4.2 Zeus Scientific Description and Business Overview
6.4.3 Zeus Scientific Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zeus Scientific Lyme Disease IgG ELISA Kit Product Portfolio
6.4.5 Zeus Scientific Recent Developments/Updates
6.5 Novatein Bioscience
6.5.1 Novatein Bioscience Corporation Information
6.5.2 Novatein Bioscience Description and Business Overview
6.5.3 Novatein Bioscience Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Novatein Bioscience Lyme Disease IgG ELISA Kit Product Portfolio
6.5.5 Novatein Bioscience Recent Developments/Updates
6.6 Serion Diagnostics
6.6.1 Serion Diagnostics Corporation Information
6.6.2 Serion Diagnostics Description and Business Overview
6.6.3 Serion Diagnostics Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Serion Diagnostics Lyme Disease IgG ELISA Kit Product Portfolio
6.6.5 Serion Diagnostics Recent Developments/Updates
6.7 Medline
6.6.1 Medline Corporation Information
6.6.2 Medline Description and Business Overview
6.6.3 Medline Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medline Lyme Disease IgG ELISA Kit Product Portfolio
6.7.5 Medline Recent Developments/Updates
6.8 Igenex
6.8.1 Igenex Corporation Information
6.8.2 Igenex Description and Business Overview
6.8.3 Igenex Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Igenex Lyme Disease IgG ELISA Kit Product Portfolio
6.8.5 Igenex Recent Developments/Updates
6.9 GeneProof
6.9.1 GeneProof Corporation Information
6.9.2 GeneProof Description and Business Overview
6.9.3 GeneProof Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GeneProof Lyme Disease IgG ELISA Kit Product Portfolio
6.9.5 GeneProof Recent Developments/Updates
6.10 Thermo Fisher Scientific
6.10.1 Thermo Fisher Scientific Corporation Information
6.10.2 Thermo Fisher Scientific Description and Business Overview
6.10.3 Thermo Fisher Scientific Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Thermo Fisher Scientific Lyme Disease IgG ELISA Kit Product Portfolio
6.10.5 Thermo Fisher Scientific Recent Developments/Updates
6.11 Everlywell
6.11.1 Everlywell Corporation Information
6.11.2 Everlywell Lyme Disease IgG ELISA Kit Description and Business Overview
6.11.3 Everlywell Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Everlywell Lyme Disease IgG ELISA Kit Product Portfolio
6.11.5 Everlywell Recent Developments/Updates
6.12 Cortez Diagnostics
6.12.1 Cortez Diagnostics Corporation Information
6.12.2 Cortez Diagnostics Lyme Disease IgG ELISA Kit Description and Business Overview
6.12.3 Cortez Diagnostics Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Cortez Diagnostics Lyme Disease IgG ELISA Kit Product Portfolio
6.12.5 Cortez Diagnostics Recent Developments/Updates
6.13 Pyramid
6.13.1 Pyramid Corporation Information
6.13.2 Pyramid Lyme Disease IgG ELISA Kit Description and Business Overview
6.13.3 Pyramid Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Pyramid Lyme Disease IgG ELISA Kit Product Portfolio
6.13.5 Pyramid Recent Developments/Updates
6.14 Abcam
6.14.1 Abcam Corporation Information
6.14.2 Abcam Lyme Disease IgG ELISA Kit Description and Business Overview
6.14.3 Abcam Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Abcam Lyme Disease IgG ELISA Kit Product Portfolio
6.14.5 Abcam Recent Developments/Updates
6.15 Fujirebio
6.15.1 Fujirebio Corporation Information
6.15.2 Fujirebio Lyme Disease IgG ELISA Kit Description and Business Overview
6.15.3 Fujirebio Lyme Disease IgG ELISA Kit Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Fujirebio Lyme Disease IgG ELISA Kit Product Portfolio
6.15.5 Fujirebio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lyme Disease IgG ELISA Kit Industry Chain Analysis
7.2 Lyme Disease IgG ELISA Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lyme Disease IgG ELISA Kit Production Mode & Process
7.4 Lyme Disease IgG ELISA Kit Sales and Marketing
7.4.1 Lyme Disease IgG ELISA Kit Sales Channels
7.4.2 Lyme Disease IgG ELISA Kit Distributors
7.5 Lyme Disease IgG ELISA Kit Customers
8 Lyme Disease IgG ELISA Kit Market Dynamics
8.1 Lyme Disease IgG ELISA Kit Industry Trends
8.2 Lyme Disease IgG ELISA Kit Market Drivers
8.3 Lyme Disease IgG ELISA Kit Market Challenges
8.4 Lyme Disease IgG ELISA Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
